Stefan Grant to Hematologic Diseases
This is a "connection" page, showing publications Stefan Grant has written about Hematologic Diseases.
Connection Strength
0.032
-
Allendorf DJ, Bordoni RE, Grant SC, Saleh MN, Reddy VB, Jerome ML, Dixon PM, Miley DK, Singh KP, Robert F. Phase I/IIa study of sequential chemotherapy regimen of bendamustine/irinotecan followed by etoposide/carboplatin in untreated patients with extensive disease small cell lung cancer (EDSCLC). Cancer Chemother Pharmacol. 2015 Nov; 76(5):949-55.
Score: 0.032